Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Increased ratio of mature BDNF to precursor-BDNF in patients with major depressive disorder with severe anhedonia
Congchong Wu, Jing Lü, Shaojia Lu, et al.
Journal of Psychiatric Research (2020) Vol. 126, pp. 92-97
Closed Access | Times Cited: 20

Showing 20 citing articles:

Brain-Derived Neurotrophic Factor (BDNF) as a biomarker of treatment response in patients with Treatment Resistant Depression (TRD): A systematic review & meta-analysis
Shakila Meshkat, Yazen Alnefeesi, Muhammad Youshay Jawad, et al.
Psychiatry Research (2022) Vol. 317, pp. 114857-114857
Closed Access | Times Cited: 42
Inflammatory cytokines, complement factor H and anhedonia in drug-naïve major depressive disorder
Wei Tang, Hongyang Liu, Lixian Chen, et al.
Brain Behavior and Immunity (2021) Vol. 95, pp. 238-244
Closed Access | Times Cited: 39
Aberrant interhemispheric functional connectivity in major depressive disorder with and without anhedonia
Shaojia Lu, Jiamin Shao, Qian Feng, et al.
BMC Psychiatry (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 22
The characteristics of anhedonia in depression: a review from a clinically oriented perspective
Congchong Wu, Qingli Mu, Weijia Gao, et al.
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access
Increased plasma levels of IL-6 are associated with striatal structural atrophy in major depressive disorder patients with anhedonia
Shaojia Lu, Congchong Wu, Lili Jia, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 20
Altered hippocampal subfield volumes in major depressive disorder with and without anhedonia
Congchong Wu, Lili Jia, Qingli Mu, et al.
BMC Psychiatry (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 11
Association of anhedonia with brain-derived neurotrophic factor and interleukin-10 in major depressive disorder
Lirong Fu, Juanjuan Ren, Xiaoxia Lei, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 133, pp. 111023-111023
Closed Access | Times Cited: 2
Edaravone Alleviated Propofol-Induced Neurotoxicity in Developing Hippocampus by mBDNF/TrkB/PI3K Pathway
Yangliang Yang, Jing Yi, Mengzhi Pan, et al.
Drug Design Development and Therapy (2021) Vol. Volume 15, pp. 1409-1422
Open Access | Times Cited: 16
The impacts of anhedonia on brain functional alterations in patients with major depressive disorder: A resting-state functional magnetic resonance imaging study of regional homogeneity
Zhe Fang, Qingli Mu, Congchong Wu, et al.
Journal of Psychiatric Research (2022) Vol. 156, pp. 84-90
Closed Access | Times Cited: 12
Combined serum IL-6, C-reactive protein, and cortisol may distinguish patients with anhedonia in major depressive disorder
Yinghui Li, Yingying Yue, Suzhen Chen, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 9
Association between Activity and Brain-Derived Neurotrophic Factor in Patients with Non-Alcoholic Fatty Liver Disease: A Data-Mining Analysis
Ryuki Hashida, Dan Nakano, Sakura Yamamura, et al.
Life (2021) Vol. 11, Iss. 8, pp. 799-799
Open Access | Times Cited: 12
From a Cycle to a Period: The Potential Role of BDNF as Plasticity and Phase-Specific Biomarker in Cocaine Use Disorder
Mauro Pettorruso, Andrea Miuli, Giacomo d’Andrea, et al.
Current Neuropharmacology (2022) Vol. 20, Iss. 11, pp. 2024-2028
Open Access | Times Cited: 7
Baseline Plasma BDNF Levelsare Associated with Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Major Depressive Disorder
Wei Zheng, Li-Mei Gu, Yanling Zhou, et al.
Current Neuropharmacology (2022) Vol. 21, Iss. 4, pp. 1013-1021
Open Access | Times Cited: 7
Change of Circulating Vascular Endothelial Growth Factor Level and Reduction of Anhedonia Are Associated in Patients With Major Depressive Disorder Treated With Repetitive Transcranial Magnetic Stimulation
Mónika Eleméry, Szilvia Kiss, Péter Döme, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 5
Brain-derived neurotrophic factor blood levels after electroconvulsive therapy in patients with mental disorders: A systematic review and meta-analysis
Zuxing Wang, Zhili Zou, Jun Xiao, et al.
General Hospital Psychiatry (2023) Vol. 83, pp. 86-92
Closed Access | Times Cited: 2
Anhedonia difference between major depressive disorder and bipolar disorder II
Xinyu Fang, Dandan Wang, Wei Tang, et al.
BMC Psychiatry (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 5
The Notch3 Pathway in Organ Fibrosis
Alejandro Egea-Zorrilla, Zuri馿 Blasco-Iturri, Borja Sáez, et al.
Deleted Journal (2024) Vol. 2, Iss. 4, pp. 10007-10007
Closed Access
Exploring peripheral biomarkers in psychostimulant use: a systematic review on neurotrophins, stress-related hormones, oxidative stress molecules and genetic factors.
Gianluca Mancusi, Andrea Miuli, Mario Santorelli, et al.
Behavioural Brain Research (2024) Vol. 469, pp. 115046-115046
Closed Access
Graph convolutional network with attention mechanism improve major depressive depression diagnosis based on plasma biomarkers and neuroimaging data
Chaonan Jiang, Bo Lin, X. Ye, et al.
Journal of Affective Disorders (2024) Vol. 360, pp. 336-344
Closed Access
The Outstanding Beneficial Roles of Irisin in Depressive Disorders
Şermin Algül, Saadet Ilcin, Oğuz Özçelik
Endokrynologia Polska (2021)
Open Access | Times Cited: 1
Page 1

Scroll to top